Genedrive Share Discussion Threads

[bunz3] 02/2/2021 13:28

like how sellers shares been bought up ,important to get sellers out at each level

[richardp19] 02/2/2021 13:26

Bgf sells being absorbed then dropping in an hour later. Think we will see a push to 97-98 in due course

[milliecusto] 02/2/2021 13:25

Stupid to sell now, just got going

[bunz3] 02/2/2021 13:24

Hooded Claw,Thank you for sharing so helpful research

this a long term hold for me ,

[andymunchkin] 02/2/2021 13:24

WhoseSelling?

[bunz3] 02/2/2021 13:23

with last weeks rns



be hoping £1 soon past


and hoping then £2 soon past


how many will want to be holding mid February


like this part of rns




The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing.



David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

[seball] 02/2/2021 13:16

Quick move to £2 then onwards and upwards to £5

[hooded claw] 02/2/2021 13:16

Best to just sit back and enjoy. The rollout should be quick from mid-Feb with BC rolling out to a series of states. 8 was mentioned as the initial roll out last year. Then the POC will be released Q1 on top of that and still waiting news of the double digit millions EU order.People must be mad or desperate to sell now.

[amir687] 02/2/2021 13:15

We have gone above the trend line already on trading view so its all looking positive from now onwards

[amir687] 02/2/2021 13:14

We should hit 1 before close of market today

[bunz3] 02/2/2021 13:13

will £1 be broken this afternoon

or will £1,20 be seen

[bunz3] 02/2/2021 13:12

buys building up again


looking like a strong afternoon ahead

[andymunchkin] 02/2/2021 13:10

DroppingLije aStone

[andymunchkin] 02/2/2021 13:10

Aeging zacStyle

[seball] 02/2/2021 12:49

This is going to rerate. Zac mir 200p Target will be history next few weeks. This is going alot higher. Strong Buy

[hazl] 02/2/2021 12:24

Wow excellent posts.
Well done guys....Richard good points.


Just looking in.

GDR is in excellent shape with the commercial roll out expected in mid -February this is going to build imo

[bunz3] 02/2/2021 12:22

now NT to buy again

[richardp19] 02/2/2021 12:21

Added 529 shares to the pot

[bunz3] 02/2/2021 12:20

shorters getting burnt

as more load up with shares

[bunz3] 02/2/2021 12:19

as next week gets closer to Mid February

hoping share price be much higher


are some thinking a share price around £2 or £3 might be seen in next number of weeks after last weeks rns

Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing


David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations

[andymunchkin] 02/2/2021 12:19

LooksLike urMates offLoading

[andymunchkin] 02/2/2021 12:19

Bunz yrA madRamper

[andymunchkin] 02/2/2021 12:18

I meant topSlicing